1|Page
NR 293 EXAM 1 / NR 293 PHARMACOLOGY EXAM 1
NEWEST ACTUAL EXAM COMPLETE 100 QUESTIONS
AND CORRECT DETAILED ANSWERS (VERIFIED
ANSWERS) |ALREADY GRADED A+ (CHAMBERLAINE
COLLEGE OF NURSING)/ BRAND NEW!!!
Chemical name - Answer-Describes the drug's chemical
composition and molecular structure
Ex: (+/-)-2-(p-isobutylephenyl) propionic acid
Generic name - Answer-Nonproprietary name
-Given by the United States Adopted Names Council
-Used in most official drug compendiums to list drugs
Ex: Ibuprofen
Trade name - Answer-Proprietary name
-The drug has a registered trademark; use of the name is
restricted by the drug's patent owner (usually the
manufacturer)
Ex: Motrin, others
,2|Page
____________ determines the rate of drug dissolution -
Answer-Dosage form
Drug dissolution - Answer-dissolving of solid dosage forms
and their absorption from the GI tract
Fastest drug absorption - Answer-Oral disintegration,
buccal tablets, oral soluable wafers
Slowest drug absorption - Answer-Enteric-coated tablets
Drug absorption from fastest to slowest - Answer--Oral
disintegration, buccal tablets, oral soluable wafers
-Liquids, elixirs, and syrups
-Suspension solutions
-Powders
-Capsules
-Tablets
-Coated tablets
-Enteric-coated tablets
,3|Page
Absorption - Answer-Movement of a drug from its site of
administration into the blood stream for distribution to the
tissues
Bioavailablitiy - Answer-Extent of drug absorption
Medication routes - Answer--Enteral
-Parenteral
-Topical
Enteral - Answer-(GI tract)
-orally vs sublingual and buccal routes, G tube
-First pass effect, variable absorption
Patenteral - Answer--Intravenous (IV)
-Intramuscular (IM)
Intravenous (IV) - Answer-Rapid onset
Avoid first pass effect
IV: Nursing considerations - Answer-Monitor drug
, 4|Page
Check for compatibilities
Monitor IV site
Intramuscular (IM) - Answer-Subcutaneously
Topical - Answer-Avoid first-pass effect, except rectal
administration
-Transdermal
-Topical
Transdermal - Answer-Deliver constant amount
Slower onset, prolong duration
Patent life - Answer-Length of time from patent approval
until patent expiration
-Normally 17 years in newly discovered drug molecule
Biosimilar - Answer-Copy version of an already authorized
biological product
-New category of the generic drug market
NR 293 EXAM 1 / NR 293 PHARMACOLOGY EXAM 1
NEWEST ACTUAL EXAM COMPLETE 100 QUESTIONS
AND CORRECT DETAILED ANSWERS (VERIFIED
ANSWERS) |ALREADY GRADED A+ (CHAMBERLAINE
COLLEGE OF NURSING)/ BRAND NEW!!!
Chemical name - Answer-Describes the drug's chemical
composition and molecular structure
Ex: (+/-)-2-(p-isobutylephenyl) propionic acid
Generic name - Answer-Nonproprietary name
-Given by the United States Adopted Names Council
-Used in most official drug compendiums to list drugs
Ex: Ibuprofen
Trade name - Answer-Proprietary name
-The drug has a registered trademark; use of the name is
restricted by the drug's patent owner (usually the
manufacturer)
Ex: Motrin, others
,2|Page
____________ determines the rate of drug dissolution -
Answer-Dosage form
Drug dissolution - Answer-dissolving of solid dosage forms
and their absorption from the GI tract
Fastest drug absorption - Answer-Oral disintegration,
buccal tablets, oral soluable wafers
Slowest drug absorption - Answer-Enteric-coated tablets
Drug absorption from fastest to slowest - Answer--Oral
disintegration, buccal tablets, oral soluable wafers
-Liquids, elixirs, and syrups
-Suspension solutions
-Powders
-Capsules
-Tablets
-Coated tablets
-Enteric-coated tablets
,3|Page
Absorption - Answer-Movement of a drug from its site of
administration into the blood stream for distribution to the
tissues
Bioavailablitiy - Answer-Extent of drug absorption
Medication routes - Answer--Enteral
-Parenteral
-Topical
Enteral - Answer-(GI tract)
-orally vs sublingual and buccal routes, G tube
-First pass effect, variable absorption
Patenteral - Answer--Intravenous (IV)
-Intramuscular (IM)
Intravenous (IV) - Answer-Rapid onset
Avoid first pass effect
IV: Nursing considerations - Answer-Monitor drug
, 4|Page
Check for compatibilities
Monitor IV site
Intramuscular (IM) - Answer-Subcutaneously
Topical - Answer-Avoid first-pass effect, except rectal
administration
-Transdermal
-Topical
Transdermal - Answer-Deliver constant amount
Slower onset, prolong duration
Patent life - Answer-Length of time from patent approval
until patent expiration
-Normally 17 years in newly discovered drug molecule
Biosimilar - Answer-Copy version of an already authorized
biological product
-New category of the generic drug market
